Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Alcon, AMO Try DTC Ads To Accelerate Presbyopia IOL Market Growth

This article was originally published in The Gray Sheet

Executive Summary

Alcon is testing a direct-to-consumer advertising campaign to help accelerate adoption of its AcrySof ReStor multifocal intraocular lens (IOL) for presbyopia, according to the firm

You may also be interested in...

Intraocular Lens Makers See Unmet Need For Fully “Accommodating” Product

Integrating the merits of various intraocular lens (IOL) implants into a single "accommodating" IOL remains the Holy Grail of eye care companies

Refractive IOL Market On Track To Approach $1 Bil. By 2010, AMO Asserts

Advanced Medical Optics projects the worldwide refractive intraocular lens market will reach $180 mil.-$200 mil. this year and approach $1 bil. by 2010, based on accelerating uptake of the technology

B&L’s MoistureLoc Worldwide Recall: Firm Ties Formulation To Infection

With evidence pointing to the basic formulation of Bausch & Lomb's ReNu with MoistureLoc contact lens solution as a contributing factor in an outbreak of serious eye infections, the company bit the bullet May 15 and issued a permanent, worldwide recall of the lucrative product

Related Content




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts